5-HT4-elicited Positive Inotropic Response is Mediated by CAMP and Regulated by PDE3 in Failing Rat and Human Cardiac Ventricles

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2008 Oct 11

PMID 18846035

Citations 18

Authors

F Afzal

K W Andressen

H K Mork

J M Aronsen

I Sjaastad

C P Dahl

T Skomedal

F O Levy

J-B Osnes

E Qvigstad

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: The left ventricle in failing hearts becomes sensitive to 5-HT parallelled by appearance of functional G(s)-coupled 5-HT(4) receptors. Here, we have explored the regulatory functions of phosphodiesterases in the 5-HT(4) receptor-mediated functional effects in ventricular muscle from failing rat and human heart.

Experimental Approach: Extensive myocardial infarctions were induced by coronary artery ligation in Wistar rats. Contractility was measured in left ventricular papillary muscles of rat, 6 weeks after surgery and in left ventricular trabeculae from explanted human hearts. cAMP was quantified by RIA.

Key Results: In papillary muscles from postinfarction rat hearts, 5-HT(4) stimulation exerted positive inotropic and lusitropic effects and increased cAMP. The inotropic effect was increased by non-selective PDE inhibition (IBMX, 10 microM) and selective inhibition of PDE3 (cilostamide, 1 microM), but not of PDE2 (EHNA, 10 microM) or PDE4 (rolipram, 10 microM). Combined PDE3 and PDE4 inhibition enhanced inotropic responses beyond the effect of PDE3 inhibition alone, increased the sensitivity to 5-HT, and also revealed an inotropic response in control (sham-operated) rat ventricle. Lusitropic effects were increased only during combined PDE inhibition. In failing human ventricle, the 5-HT(4) receptor-mediated positive inotropic response was regulated by PDEs in a manner similar to that in postinfarction rat hearts.

Conclusions And Implications: 5-HT(4) receptor-mediated positive inotropic responses in failing rat ventricle were cAMP-dependent. PDE3 was the main PDE regulating this response and involvement of PDE4 was disclosed by concomitant inhibition of PDE3 in both postinfarction rat and failing human hearts. 5-HT, PDE3 and PDE4 may have pathophysiological functions in heart failure.

Citing Articles

Tegaserod Stimulates 5-HT Serotonin Receptors in the Isolated Human Atrium.

Hesse C, Neumann J, Compan V, Ponimaskin E, Muller F, Hofmann B Int J Mol Sci. 2024; 25(20).

PMID: 39456915 PMC: 11508481. DOI: 10.3390/ijms252011133.

Zacopride stimulates 5-HT serotonin receptors in the human atrium.

Neumann J, Hesse C, Hofmann B, Gergs U Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6821-6835.

PMID: 38557827 PMC: 11422277. DOI: 10.1007/s00210-024-03051-5.

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease.

Neumann J, Hofmann B, Dhein S, Gergs U Int J Mol Sci. 2023; 24(5).

PMID: 36902195 PMC: 10003731. DOI: 10.3390/ijms24054765.

Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts.

Calamera G, Moltzau L, Levy F, Andressen K Int J Mol Sci. 2022; 23(4).

PMID: 35216259 PMC: 8880502. DOI: 10.3390/ijms23042145.

Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H-histamine-receptor activation in isolated atria of transgenic mice.

Neumann J, Voss R, Laufs U, Werner C, Gergs U Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(6):1215-1229.

PMID: 33576869 PMC: 8208929. DOI: 10.1007/s00210-021-02052-y.

References

Lugnier C, Keravis T, Le Bec A, Pauvert O, Proteau S, Rousseau E . Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei. Biochim Biophys Acta. 1999; 1472(3):431-46. DOI: 10.1016/s0304-4165(99)00145-2. View

Galindo-Tovar A, Kaumann A . Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors. Br J Pharmacol. 2007; 153(4):710-20. PMC: 2259196. DOI: 10.1038/sj.bjp.0707631. View

Rich T, Fagan K, Tse T, Schaack J, Cooper D, Karpen J . A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc Natl Acad Sci U S A. 2001; 98(23):13049-54. PMC: 60822. DOI: 10.1073/pnas.221381398. View

Antos C, Frey N, Marx S, Reiken S, Gaburjakova M, Richardson J . Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res. 2001; 89(11):997-1004. DOI: 10.1161/hh2301.100003. View

Zaccolo M, Pozzan T . Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 2002; 295(5560):1711-5. DOI: 10.1126/science.1069982. View

Cuffe M, Califf R, Adams Jr K, Benza R, Bourge R, Colucci W . Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002; 287(12):1541-7. DOI: 10.1001/jama.287.12.1541. View

Beavo J, Brunton L . Cyclic nucleotide research -- still expanding after half a century. Nat Rev Mol Cell Biol. 2002; 3(9):710-8. DOI: 10.1038/nrm911. View

Takahashi K, Osanai T, Nakano T, Wakui M, Okumura K . Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure. Heart Vessels. 2002; 16(6):249-56. DOI: 10.1007/s003800200032. View

Baillie G, Sood A, McPhee I, Gall I, Perry S, Lefkowitz R . beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci U S A. 2003; 100(3):940-5. PMC: 298705. DOI: 10.1073/pnas.262787199. View

10.

SCHUMANN H, Endo M, Wagner J . Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by alpha- and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1974; 284(2):133-48. DOI: 10.1007/BF00501118. View

11.

Sole M, Shum A, Van Loon G . Serotonin metabolism in the normal and failing hamster heart. Circ Res. 1979; 45(5):629-34. DOI: 10.1161/01.res.45.5.629. View

12.

Skomedal T, Grynne B, Osnes J, Sjetnan A, Oye I . A radioimmunoassay for cyclic AMP (cAMP) obtained by acetylation of both unlabeled and labeled (3H-cAMP) ligand, or of unlabeled ligand only. Acta Pharmacol Toxicol (Copenh). 1980; 46(3):200-4. DOI: 10.1111/j.1600-0773.1980.tb02443.x. View

13.

Shahid M, Nicholson C . Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(6):698-705. DOI: 10.1007/BF00175715. View

14.

Movsesian M, Smith C, KRALL J, Bristow M, Manganiello V . Sarcoplasmic reticulum-associated cyclic adenosine 5'-monophosphate phosphodiesterase activity in normal and failing human hearts. J Clin Invest. 1991; 88(1):15-9. PMC: 295996. DOI: 10.1172/JCI115272. View

15.

Packer M, Carver J, Rodeheffer R, Ivanhoe R, DiBianco R, Zeldis S . Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991; 325(21):1468-75. DOI: 10.1056/NEJM199111213252103. View

16.

Chandra M, Gupta V, Johri A, Misra R, Kumar A, Gujrati V . Serotonergic mechanisms in heart failure. Indian Heart J. 1994; 46(4):153-6. View

17.

Alexander S, Mathie A, Peters J . Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol. 2008; 153 Suppl 2:S1-209. PMC: 2275471. DOI: 10.1038/sj.bjp.0707746. View

18.

Skomedal T, Borthne K, Aass H, Geiran O, Osnes J . Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle. J Pharmacol Exp Ther. 1997; 280(2):721-9. View

19.

Smith C, Huang R, Sun D, Ricketts S, Hoegler C, Ding J . Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A. Circulation. 1997; 96(9):3116-23. DOI: 10.1161/01.cir.96.9.3116. View

20.

Xiang Y, Naro F, Zoudilova M, Catherine Jin S, Conti M, Kobilka B . Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes. Proc Natl Acad Sci U S A. 2005; 102(3):909-14. PMC: 544184. DOI: 10.1073/pnas.0405263102. View